BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17703420)

  • 1. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
    Rowhani-Rahbar A; Hawes SE; Sow PS; Toure P; Feng Q; Dem A; Dembele B; Critchlow CW; N'Doye I; Kiviat NB
    J Infect Dis; 2007 Sep; 196(6):887-94. PubMed ID: 17703420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
    Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
    J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.
    Koshiol J; Schroeder J; Jamieson DJ; Marshall SW; Duerr A; Heilig CM; Shah KV; Klein RS; Cu-Uvin S; Schuman P; Celentano D; Smith JS
    Am J Epidemiol; 2006 Jul; 164(2):176-83. PubMed ID: 16775041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse.
    Drobacheff C; Dupont P; Mougin C; Bourezane Y; Challier B; Fantoli M; Bettinger D; Laurent R
    Eur J Dermatol; 2003; 13(4):367-71. PubMed ID: 12948917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.
    Fontaine J; Hankins C; Money D; Rachlis A; Pourreaux K; Ferenczy A; ; Coutlée F
    J Clin Virol; 2008 Nov; 43(3):307-12. PubMed ID: 18786854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
    J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples.
    Mbulawa ZZ; Marais DJ; Johnson LF; Boulle A; Coetzee D; Williamson AL
    J Gen Virol; 2010 Dec; 91(Pt 12):3023-31. PubMed ID: 20719990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
    Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
    Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.